Mark Lawler: Our Manifesto on improving cancer care in conflict-impacted regions

Mark Lawler shared a post by European Cancer Organisation on X:

“Please support our Manifesto on improving cancer care in conflict-impacted regions.

We have to support those cancer patients and cancer systems that are suffering the collateral damage of war.

Endorse the Manifesto.

Email your logo to [email protected] .”

Quoting European Cancer Organisation’s post:

“The newly released ‘Manifesto on improving cancer care in conflict-impacted populations’ outlines seven steps to ensure cancer patients receive appropriate treatment No Matter What Endorse the Manifesto.

Email your logo at [email protected] .”

Source: Mark Lawler/X and European Cancer Organisation/X

Professor Mark Lawler holds the positions of Associate Pro-Vice-Chancellor, Professor of Digital Health, and Chair in Translational Cancer Genomics at the Faculty of Medicine, Health and Life Sciences at Queen’s University Belfast (QUB). He serves on the Board of the European Alliance for Personalised Medicine (EAPM) and was instrumental in developing EAPM’s research strategy.

Additionally, he is a member of the Scientific Advisory Board of the European Cancer Patient Coalition and the Strategic Advisory Board of Genomics England. His expertise includes genetics, precision medicine, health data, COVID-19, cancer, and patient and public involvement in research.